Skin Burn Or Open Wound Treatment Patents (Class 424/78.06)
-
Patent number: 8440209Abstract: The invention relates to adhesives for medical applications and methods of their preparation and use.Type: GrantFiled: March 1, 2011Date of Patent: May 14, 2013Assignee: Stryker Trauma GmbHInventors: Andreas Speitling, Philip Procter, Joachim Schomburg, Christian Schultz, Wolf-Dieter Jülich, Ulrike Lindequist, Frieder Schauer, Annett Mikolasch, Katrin Manda
-
Patent number: 8399027Abstract: A silver composition comprising silver sulfate and a method of coating the composition on a substrate is disclosed.Type: GrantFiled: January 13, 2006Date of Patent: March 19, 2013Assignee: 3M Innovative Properties CompanyInventors: Scott A. Burton, David R. Holm
-
Publication number: 20130060208Abstract: The present invention relates to wound care products, devices and methods incorporating acetic acid for the treatment of bacterial infections, in particular bacterial biofilm infections. In particular it relates to a wound care product comprising acetic acid, wherein the product comprises at least one further antibacterial compound; a delivery system comprising a container connected to a means of delivery which is connected to a pad, wherein said container comprises a composition comprising acetic acid and said pad comprises a self-adhesive material; a kit comprising a dressing and an adhesive membrane, wherein the dressing comprises a composition comprising acetic acid; a method of treating a wound comprising a) applying acetic acid to the wound and b) applying a negative pressure to the wound.Type: ApplicationFiled: December 21, 2010Publication date: March 7, 2013Applicants: RIGSHOSPITALET, COPENHAGEN UNIVERSITY HOSPITAL, BISPEBJERG HOSPITAL, DANMARKS TEKNISKE UNIVERSITETInventors: Michael Christian Givskov, Thomas Bjarnsholt, Klaus Kirketerp-Møller
-
Patent number: 8388946Abstract: The present invention relates in its broadest aspect to combined phage/antibiotic therapy. More particularly, it relates to use of (i) one or more bacteriophages and (ii) one or more antibiotics in the manufacture of a combined product for simultaneous, separate or sequential administration of (i) and (ii) to treat a bacterial infection characterized by biofilm formation, for example an infection comprising or consisting of P. aeruginosa. Treatment in this context may be either therapeutic or prophylactic treatment. Also provided are deposited bacteriophages each exhibiting different strain specificity against P. aeruginosa and combinations of such bacteriophages, e.g. a panel of six deposited bacteriophages which was found to be effective against a high percentage of clinical isolates of P. aeruginosa from canine ear infections.Type: GrantFiled: December 21, 2011Date of Patent: March 5, 2013Assignee: BioControl LimitedInventors: James Soothill, Catherine Hawkins, David Harper
-
Publication number: 20130052152Abstract: The present invention provides a wound dressing comprising a tessellated water-soluble molding matrix comprised of a polymer selected from the group consisting of polyvinyl alcohol, gelatin, and mixtures thereof and a 1,1-disubstituted ethylene monomer. The present invention further provides methods of using the wound dressing and kits containing the wound dressing.Type: ApplicationFiled: August 25, 2011Publication date: February 28, 2013Inventor: Scott Alan Keplinger
-
Publication number: 20130052153Abstract: A method of preparing hydrogel structure, wherein the hydrogel structure comprises: (a) a one way penetrating polyurethane film layer, (b) a hydrophobic pressure sensitive adhesive layer, (c) a multi-directional elastic meltblown nonwoven, (d) an interpenetrating polymer network, and (e) a hydrophilic hydrogel; and the method comprises: (i) coating the hydrogel in a form of solution on the meltblown non-woven to form a product 1, (ii) UV curing the product 1 in step (i), forming a composite comprising a hydrogel layer on the top, an interpenetrating polymer network in the middle, and a meltblown non-woven layer on the bottom, wherein the interpenetrating polymer network is a mixture of the hydrogel and the meltblown non-woven, (iii) providing polyurethane film layer coated with pressure sensitive adhesive layer, and (iv) laminating part of exposed fibers of meltblown non-woven with the pressure sensitive adhesive layer, forming a hydrogel structure.Type: ApplicationFiled: May 2, 2012Publication date: February 28, 2013Applicant: COMPOSE ELEMENT LIMITEDInventor: Tsu-Tai Lin
-
Patent number: 8377679Abstract: The present invention pertains to the use of probiotics for the preparation of a carrier for balancing the skin's immune function. In particular, the present invention pertains to the use of probiotic micro-organisms for balancing the skin's immune function under stress conditions, such as a exposure to ultraviolet radiation, specifically for enhancing the skin's immune activity and reducing the tendency to develop allergic reactions under such conditions.Type: GrantFiled: August 7, 2009Date of Patent: February 19, 2013Assignee: Nestec S.A.Inventors: Markus Baur, Lionel Breton, Francois Couzy, Audrey Gueniche
-
Patent number: 8349304Abstract: A liquid evaporative cooling composition, for providing relief from heat-related discomfort in humans and animals, is generated by means of a concentrate, dissolved in water, which preferably consists essentially of: (a) about forty-three percent by weight of an alcohol; (b) about twelve percent by weight of a surfactant; (c) about four percent by weight of an aromatic oil; (d) about one percent by weight of a cooling agent; and (e) about forty percent by weight of water.Type: GrantFiled: July 7, 2006Date of Patent: January 8, 2013Inventors: Kerri Lynn Tate, Carl Patrick Tate, Albert Scott Adamson, Jr.
-
Patent number: 8349987Abstract: The disclosure relates to biocompatible components useful for forming compositions for use as medical/surgical synthetic adhesives and sealants. Biocompatible components of the present disclosure may include a polymeric polyol core, which may be treated with a nitroaryl compound to form a nitro ester. The resulting nitro ester groups may be reduced to form amino groups which, in turn, may be treated to form isocyanate groups. The resulting isocyanate may then be reacted with a second component to form adhesive and/or sealant compositions.Type: GrantFiled: February 2, 2010Date of Patent: January 8, 2013Assignee: Covidien LPInventors: Mbiya Kapiamba, Jack Kennedy, Roland Ostapoff
-
Publication number: 20120321695Abstract: The invention concerns a method for the production of a pharmaceutical preparation for the treatment of Herpes forms that is characterized in that the preparation comprises at least one antiseptic compound associated with a particular carrier.Type: ApplicationFiled: June 1, 2012Publication date: December 20, 2012Inventors: Karen REIMER, Wolfgang Fleischer
-
Patent number: 8323693Abstract: There is provided an external preparation for wounds which has novel usability in treating skin damages accompanied by a large amount of exudation such as bedsores, skin ulcers, and burns, and yet has such advantages as observed in conventional medicines having been employed in treating these wounds. The external preparation for wounds comprises a water-soluble polymer and a crosslinking agent, and has powdery/granular or ointment form. After absorbing an exudation, the preparation undergoes phase transition from a sol to a gel by the action of ingredient of the preparation, and thus exhibits actions of adsorbing and eliminating necrotic tissues, and protecting the wounded parts. Subsequently, it can continuously absorb the exudation. After being used, it can be easily separated substantially as a mass, thereby exhibiting high therapeutic effects and usability.Type: GrantFiled: March 12, 2003Date of Patent: December 4, 2012Assignees: Medrx Co., Ltd., Nippon Shinyaku Co., Ltd.Inventors: Hidetoshi Hamamoto, Keiko Yamasaki, Hideakira Yokoyama, Akihiko Hirata, Takeru Fujii
-
Publication number: 20120294823Abstract: A method for preparing a porous-three-dimensional scaffold good for tissue engineering is described. Sericin forms a three-dimensional scaffold with PVA after freeze-drying having glycerin as a plasticizer and genipin as natural crosslinking agent to help making a strong and stable matrix. Adding glycerin into scaffold gives good uniformity and porosity. Smaller pore sizes and better uniformity are obtained as the concentration of genipin in the scaffold increases. Glycerin retains a high moisture content to allow the presence of water molecule in the matrix structure. Adding genipin results in a higher degree of crosslinking within the scaffold. Crosslinking using genipin is most beneficial in preparing scaffold possesses the best biological and physical properties for wound healing. The present invention describes method for preparing crosslinked matrix whose composition can be appropriately tuned to obtain matrix with desirable characteristics for biological applications.Type: ApplicationFiled: May 16, 2011Publication date: November 22, 2012Inventor: Pornanong Aramwit
-
Publication number: 20120276039Abstract: The present invention provides aptamer-modified polymers and materials thereof, which may be used for the binding of factors in a wound bed. For example, the aptamer-modified materials can be polypeptides conjugated to polymer foam materials. Such materials may be used, for example, for dressings, wound inserts, or pads.Type: ApplicationFiled: April 27, 2012Publication date: November 1, 2012Applicant: KCI LICENSING, INC.Inventors: James Courage, Diwi Allen, Amy McNulty, Anthony Rycerz, Christopher Carroll, Douglas Hanson, Todd Fruchterman
-
Publication number: 20120269761Abstract: The present inventions in various aspects provide elastic biodegradable polymers. In various embodiments, the polymers are formed by the reaction of a multifunctional alcohol or ether and a difunctional or higher order acid to form a pre-polymer, which is cross-linked to form the elastic biodegradable polymer. In preferred embodiments, the cross-linking is performed by functionalization of one or more OR groups on the pre-polymer backbone with vinyl, followed by photopolymerization to form the elastic biodegradable polymer composition or material. Preferably, acrylate is used to add one or more vinyls to the backbone of the pre-polymer to form an acrylated pre-polymer. In various embodiments, acrylated pre-polymers are co-polymerized with one or more acrylated co-polymers.Type: ApplicationFiled: March 23, 2012Publication date: October 25, 2012Inventors: Christopher J. Bettinger, Joost P. Bruggeman, Lino Da Silva Ferreira, Jeffrey M. Karp, Robert S. Langer, Christiaan Nijst, Andreas Zumbuehl, Jason Burdick, Sonia J. Kim
-
Patent number: 8287901Abstract: A monomeric adhesive composition includes a stabilized polymerizable monomer, such as a 1,1-disubstituted monomer, including a cyanoacrylate, and a wound healing agent, wherein the wound healing agent is 5,5-disubstitutedhydantoin, including phenyloin; and a method for making said composition.Type: GrantFiled: August 11, 2010Date of Patent: October 16, 2012Assignee: Adhezion Biomedical, LLCInventors: Sheng Zhang, Rafael Ruiz, Sr.
-
Patent number: 8252333Abstract: A biological adhesive formulation comprising dextrin, at least one adhesiveness modifier agent, and at least one antibiotic is suitable for promoting healing of tissue in a patient, for example, to prevent anastomosis of a surgical wound in the digestive system of a patient, and for affixing a prosthesis during a hernia operation.Type: GrantFiled: August 22, 2006Date of Patent: August 28, 2012Inventor: Jorge Cueto-Garcia
-
Publication number: 20120213727Abstract: The invention relates to therapeutic methods comprising use of oligomeric and polymeric forms of the monoterpene compounds alloocimene, limonene, alpha-pinene, beta-pinene, geranyl acetate, alpha-phellandrene, gamma-terpinene, 3-carene and 2-carene. More particularly, the invention relates to methods of treating degenerative neurological conditions, and treating skin disorders.Type: ApplicationFiled: October 28, 2010Publication date: August 23, 2012Applicant: REGENERA PHARMA LTD.Inventor: Zadik Hazan
-
Patent number: 8221802Abstract: A unique, synergistic formulation for the treatment of first-degree skin burns is provided for topical use and alleviates the full spectrum of symptoms and concerns associated with epidermal burns, including pain, blistering, redness, swelling, compromised skin integrity, risk of infection and scarring. The formulation contains natural homeopathic extracts combined with a pharmaceutically acceptable carrier suitable for topical administration. The formulation may include three or more of the following homeopathic extracts: Cantharis Vesicatoria, Echinacea Angustifolia, Calendula Officinalis and Hypericum Perforatum.Type: GrantFiled: May 2, 2011Date of Patent: July 17, 2012Assignee: The Akshay Wellness Group, Inc.Inventor: Sai S. Manickam
-
Publication number: 20120148520Abstract: The present inventions relate to a number of fields including wound healing, a waterless antibacterial disinfectant, a surgical scrub, insect repellant, and methods of treating traumatic injuries, particularly those on the battlefield where there is a need to stabilize the patient and prevent infection.Type: ApplicationFiled: December 9, 2011Publication date: June 14, 2012Inventors: Michael Strobel, Gene Komer
-
Publication number: 20120134951Abstract: Provided according to some embodiments of the invention are topical gels that may release nitric oxide. Also provided are methods of using such topical gels in the treatment of wounds and other skin ailments. The topical gels comprise diazeniutndiolate-functionalized polysiloxane macromolecules.Type: ApplicationFiled: August 20, 2010Publication date: May 31, 2012Inventors: Nathan Stasko, Susanne Bauman, Pranav R. Joshi
-
Publication number: 20120128622Abstract: The present invention is directed to an enhanced wound healing composition, including a gel containing vancomycin, useful for the prevention of the spread of resistant-type bacteria. Preferably, the drug is one or more antibiotic agents in therapeutically effective concentrations to reduce or eliminate MRSA. The composition is based on a gel composition containing one or more gel forming compounds, such as one or more polymers, preservatives, and/or pH stabilizers and buffers, which not only maintains a moist wound environment to enhance wound healing, but also provides an antibiotic agent which has sustained potency and stability. The composition, when placed in contact with a treatment site, delivers the drug to the site. By incorporating the drug into the gel composition that is formulated to enhance wound healing, the treatment of such disease is possible in a manner which promotes wound healing while reducing or eliminating the MRSA microbe.Type: ApplicationFiled: November 17, 2011Publication date: May 24, 2012Inventor: Robert Stanley Berman
-
Publication number: 20120114591Abstract: The invention provides a method of treating a wound (for example, a chronic ulcerous skin lesion) in a human or non-human mammal (particularly a human). The wound is contacted with a topical hydrogel composition comprising a hydrophilic polymer carrying multiple pendant sulphonyl groups, optionally with multiple pendant carboxylic groups, on each polymer molecule.Type: ApplicationFiled: November 14, 2011Publication date: May 10, 2012Applicant: FIRST WATER LIMITEDInventor: Hugh Semple Munro
-
Publication number: 20120114592Abstract: Hemostatic foams Abstract The invention is directed to hemostatic foams and to the preparation of such foams. In a first aspect, the present invention provides a biodegradable hemostatic foam comprising a polymer blend of a water-soluble polymer and a phase-separated polyurethane comprising an amorphous segment and a crystalline segment, wherein at least said amorphous segment comprises a hydrophilic segment.Type: ApplicationFiled: May 27, 2010Publication date: May 10, 2012Applicant: Polyganics B.V.Inventors: Johan Zuidema, Jacob Richard de Vries, Jhacintha Sarikadevie Jankie, Rudolf Robert Maria Bos, Susan Henrieke Visscher
-
Patent number: 8147857Abstract: The present invention describes microbicidal hydrophilic polyurethane foams endowed with polyhexamethylenebiguanide (PHMB) and/or its hydrochloride and also a superabsorbent, wound contact materials obtainable therefrom and processes for producing the therapeutically endowed polyurethane foams and the wound contact materials obtainable therefrom.Type: GrantFiled: December 13, 2005Date of Patent: April 3, 2012Assignee: Bayer Innovation GmbHInventors: Burkhard Fugmann, Melita Dietze
-
Publication number: 20120070401Abstract: A composition for promoting wound healing comprises a bioadhesive polymer and a pharmaceutically acceptable liquid medium. Such a composition is applied to a wound to promote healing of the wound. The bioadhesive polymer can be selected from the group consisting of natural or synthetic hydrophilic polymers and hydrogels.Type: ApplicationFiled: August 25, 2011Publication date: March 22, 2012Inventors: Jinzhong Zhang, Keith W. Ward, Francisco J. Lopez, Matthew Jonasse
-
Publication number: 20120052111Abstract: Provided herein are protective laminate devices comprising a biocompatible non-adherent substance and a fast-setting adhesive and methods of use. Also provided is a dispenser for an adhesive tape. The protective laminate devices and methods may be used for wound closure.Type: ApplicationFiled: November 8, 2011Publication date: March 1, 2012Inventors: Kevin S. Marchitto, Stephen T. Flock
-
Patent number: 8119106Abstract: The present invention is related to a foamable composition of matter comprising iodine, water, a foam adjuvant, a surface-active agent and a gelling agent. This foamable composition, which may be provided in a propellant free foaming device, or alternatively may further comprise a propellant, evolves into foam, which is effective in the topical treatment and prevention of various skin disorders.Type: GrantFiled: July 8, 2009Date of Patent: February 21, 2012Assignee: Foamix LtdInventors: Dov Tamarkin, Doron Friedman, Meir Eini
-
Publication number: 20120039838Abstract: A monomeric adhesive composition includes a stabilized polymerizable monomer, such as a 1,1-disubstituted monomer, including a cyanoacrylate, and a wound healing agent, wherein the wound healing agent is 5,5-disubstitutedhydantoin, including phenyloin; and a method for making said composition.Type: ApplicationFiled: August 11, 2010Publication date: February 16, 2012Applicant: ADHEZION BIOMEDICAL, LLCInventors: Sheng Zhang, Rafael Ruiz, SR.
-
Patent number: 8101206Abstract: The present invention provides a method of attenuating the formation or reducing the severity of swelling and/or inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of swelling and/or inflammation.Type: GrantFiled: September 29, 2006Date of Patent: January 24, 2012Assignee: Sessions Pharmaceuticals Inc.Inventors: Robert W. Sessions, Alan R. Kahn
-
Patent number: 8097274Abstract: Provided herein are skin substitutes suitable for use in a living subject for purpose of repairing damaged tissues, methods of producing the skin substitutes and their uses. A biocomposite membrane comprising poly(?-caprolactone) (PCL) and at least one material selected from collagen and gelatin is provided. In one embodiment, the biocomposite is a 2-component membrane of PCL and gelatin. In another embodiment, the biocomposite is a 3-component membrane of PCL, collagen and gelatin. The bio-composite membrane may be used directly in vivo as a wound dressing, or as a support for cell growth on each side of the membrane to produce an in vitro cultivated artificial skin for future in vivo and/or in vitro applications.Type: GrantFiled: October 27, 2006Date of Patent: January 17, 2012Assignee: National Defense Medical CenterInventors: Allan Gerald Arthur Coombes, Eric Frank Adams, Niann-Tzyy Dai, Tsung-Hsun Liu, Ming-Kung Yeh
-
Publication number: 20110319805Abstract: The present invention relates to a topical composition for the treatment of mammals suffering from a condition of the skin such as a skin lesion, a wound, a cut, an abrasion, a hot spot, a sore foot pad, inflamed skin or dry skin; wherein the composition contains a blend of four separate creams, a steroidal material, a normally injectable vitamin A and vitamin D composition, an antibiotic material and, optionally, ingredients such as aloe vera, an antifungal agent, an anti-parasitic agent, DMSO and a topical anaesthetic.Type: ApplicationFiled: June 21, 2011Publication date: December 29, 2011Inventor: Bryan Knicely Morris
-
Patent number: 8071555Abstract: The disclosed invention provides tetrapeptides with the amino acid sequence proline-glutamine-glutamate-X (P-Q-E-X), where X can be either lysine (K) or isoleucine (I). These tetrapeptides inhibit ultraviolet light (UV)-induced expression of the pro-inflammatory cytokine interleukin-6 (IL-6) by skin epithelial cells and fibroblasts. Furthermore, the tetrapeptides repress the upregulation of matrix metalloproteinase-1 (MMP-1) by skin fibroblasts induced by either direct exposure to UV rays or treatment with media conditioned by UV-treated keratinocytes. The small size and bio-activity of the tetrapeptides render them suitable for use in therapies directed to inflammatory skin disorders and as active ingredients in skin care products.Type: GrantFiled: October 28, 2008Date of Patent: December 6, 2011Assignee: Helix BioMedix Inc.Inventors: Lijuan Zhang, Scott M. Harris, Timothy J. Falla
-
Patent number: 8071124Abstract: Liquid, injectable, aqueous solutions are transformed in situ to an expandable foam-like, space filling, and adherent biomaterial. Preferably, the foam-like biomaterial is the reaction product of a two-part liquid system to achieve the in situ formation thereof. The liquid system is generally comprised of a protein solution and a cross linker solution which may either be premixed and then applied to a site in need of the biomaterial, or simultaneously mixed and delivered through an in-line mixing/dispensing tip directly to the site. In especially preferred embodiments, an expandable foam-like biomaterial includes the reaction product of human or animal-derived protein material and a di- or polyaldehyde in the presence of a bicarbonate and an acidic titrant amounts sufficient to impart a cellular foam structure to the material.Type: GrantFiled: January 26, 2005Date of Patent: December 6, 2011Assignee: CryoLife, Inc.Inventors: K. Umit Yuksel, Ana T. Bird, Kirby S. Black
-
Patent number: 8057818Abstract: Liquid, injectable, aqueous solutions are transformed in situ to an expandable foam-like, space filling, and adherent biomaterial. Preferably, the foam-like biomaterial is the reaction product of a two-part liquid system to achieve the in situ formation thereof. The liquid system is generally comprised of a protein solution and a cross linker solution which may either be premixed and then applied to a site in need of the biomaterial, or simultaneously mixed and delivered through an in-line mixing/dispensing tip directly to the site. In especially preferred embodiments, an expandable foam-like biomaterial includes the reaction product of human or animal-derived protein material and a di- or polyaldehyde in the presence of a bicarbonate and an acidic titrant amounts sufficient to impart a cellular foam structure to the material.Type: GrantFiled: January 26, 2005Date of Patent: November 15, 2011Assignee: CryoLife, Inc.Inventors: K. Umit Yüksel, Ana T. Bird, Kirby S. Black
-
Publication number: 20110250257Abstract: Disclosed herein is a fibrous tissue sealant in the form of an anhydrous fibrous sheet comprising a first component which is a fibrous polymer containing electrophilic or nucleophilic groups and a second component capable of crosslinking the first component when the sheet is exposed to an aqueous medium, thereby forming a crosslinked hydrogel that is adhesive to biological tissue. The fibrous tissue sealant may be useful as a general tissue adhesive for medical and veterinary applications such as wound closure, supplementing or replacing sutures or staples in internal surgical procedures, tissue repair, and to prevent post-surgical adhesions. The fibrous tissue sealant may be particularly suitable for use as a hemostatic sealant to stanch bleeding from surgical or traumatic wounds.Type: ApplicationFiled: August 31, 2009Publication date: October 13, 2011Inventors: Samuel David Arthur, Tao Huang, William Gerald Dimaio, JR., George K. Kodokian
-
Publication number: 20110171284Abstract: The present invention relates to a composition and wound dressing for delivering a composition comprising povidone-iodine and sucrose mixture. The composition is gelled and, in one embodiment, is impregnated on a gauze or other like material for application to an exuding or non-exuding wound.Type: ApplicationFiled: January 11, 2010Publication date: July 14, 2011Inventors: Miles E. Gilman, Joseph S. Bertino
-
Publication number: 20110172580Abstract: A wound care dressing comprising one or more nonwoven blankets, where each nonwoven blanket comprises a plurality of fibers, where each of the plurality of fibers are formed from one or more saccharides in optional combination with one or more medicaments.Type: ApplicationFiled: March 28, 2011Publication date: July 14, 2011Inventor: DAVID M. DIXON
-
Publication number: 20110150943Abstract: The invention relates to adhesives for medical applications and methods of their preparation and use.Type: ApplicationFiled: March 1, 2011Publication date: June 23, 2011Inventors: Andreas Werner Speitling, Philip Procter, Joachim Schomburg, Christian Schultz, Wolf-Dieter Jülich, Ulrike Lindequist, Frieder Schauer, Annett Mikolasch, Katrin Manda
-
Patent number: 7959955Abstract: A unique, synergistic formulation for the treatment of first-degree skin burns is provided for topical use and alleviates the full spectrum of symptoms and concerns associated with epidermal burns, including pain, blistering, redness, swelling, compromised skin integrity, risk of infection and scarring. The formulation contains natural homeopathic extracts combined with a pharmaceutically acceptable carrier suitable for topical administration. The formulation includes the following homeopathic extracts: Cantharis vesicatoria, Echinacea anqustifolia, Calendula officinalis and Hypericum perforatum.Type: GrantFiled: June 11, 2008Date of Patent: June 14, 2011Assignee: The Akshay Wellness Group, Inc.Inventor: Sai S. Manickam
-
Publication number: 20110123476Abstract: The disclosure relates to biocompatible components useful for forming compositions for use as medical/surgical synthetic adhesives and sealants. Biocompatible components of the present disclosure may include a multifunctional amine or multifunctional polyol core, with isocyanate and/or polyalkylene oxide arms, which may optionally be capped with electrophilic or nucleophilic groups. These biocompatible components may, in embodiments, be combined with optional cross linkers to form adhesive and/or sealant compositions.Type: ApplicationFiled: January 25, 2011Publication date: May 26, 2011Inventors: Mbiya Kapiamba, Ahmad Robert Hadba
-
Publication number: 20110117047Abstract: A sterilized cyanoacrylate adhesive composition including a cyanoacrylate composition and a cure speed enhancer, wherein said sterilized cyanoacrylate adhesive composition does not cure upon sterilization, and wherein the composition when cured to form a film on a patient's tissue has water vapor transmission rate from about 950 to about 3000 g/m2/day.Type: ApplicationFiled: June 23, 2009Publication date: May 19, 2011Applicant: ADHEZION BIOMEDICAL, LLCInventors: Sheng Zhang, Rafael Ruiz, Sr.
-
Patent number: 7923003Abstract: The invention relates to a kit comprising the following individual components: (a) polymers comprising at least one free amino group, (b) bridge molecules selected from the group consisting of monocyclic ortho-dihydroxyaromates, mono-cyclic para-dihydroxyaromates, bicyclic monohydrxyaromates, polycyclic monohydroxyaromates, bicyclic dihydroxyaromates, polycyclic dihydroxyaromates, bicyclic trihydroxyaromates, polycyclic trihydroxyaromates, and mixtures thereof, and (c) polyphenoloxidases, in particular, lignolytic polyphenoloxidases, whereby the individual components b) and c) are not in contact.Type: GrantFiled: February 9, 2007Date of Patent: April 12, 2011Assignee: Stryker Trauma GmbHInventors: Andreas Werner Speitling, Philip Procter, Joachim Schomburg, Christian Schultz, Wolf Dieter Jülich, Ulrike Lindequist, Frieder Schauer, Annett Mikolasch, Katrin Manda
-
Publication number: 20110054375Abstract: The invention relates to dressings comprising a particle mixture of polyacrylate particles for using in modern wound treatment. The invention especially relates to a dressing comprising a particle mixture of polyacrylate particles, which contains a particle fraction for inhibiting proteases in a wound and a particle fraction for absorbing or eliminating aqueous liquids.Type: ApplicationFiled: November 26, 2007Publication date: March 3, 2011Inventor: Hans Smola
-
Publication number: 20110045056Abstract: The present invention provides a hydrogel composition, preferably for the treatment of wounds, comprising a hydrophilic co-polymer carrying multiple pendant anionic groups, wherein the polymer is derived from a first monomer and a second monomer, wherein both monomers have an octanohwater partition coefficient Log P value of less than 0, and, the Log P value of the first monomer is greater (more positive) than the second monomer. Preferably the difference between the Log P value for the two monomers is at least 0.1, preferably at least 0.2. The difference between the Log P value for the two monomers is preferably less than 2. The weight ratio (w/w) of the first monomer/second monomer in the hydrogel composition is preferably equal to or more than about 1. The pendant anionic groups may be sulphonyl groups, e.g. sulphonic acid groups or salts thereof. The anionic group in both first and second monomers may be in salt form and the counterion for both monomers is preferably the same.Type: ApplicationFiled: January 16, 2009Publication date: February 24, 2011Applicant: FIRST WATER LIMITEDInventors: Hugh Semple Munro, Nicholas Boote
-
Publication number: 20110046532Abstract: A composition is formed by the step of feeding a molecule that has an active oxygen-forming species into a silicone based polymer. The silicone-based polymer is substantially free of pendant groups that are reactive with active oxygen species. Silicone-based polymers have proven scar-healing properties. As such, the composition is useful for treating skin disorders, especially scars, to reduce the appearance of the scars. Furthermore, bacteria and infections may contribute to the formation of scars. The active oxygen-forming species form active oxygen species, which oxidize pathogens including bacteria, viruses, and fungus to sterilize an area in contact with the composition. As a result, the appearance of scars treated with the composition may be even further reduced due to the presence of the molecule having the active oxygen-forming species.Type: ApplicationFiled: January 29, 2007Publication date: February 24, 2011Inventors: Sanjeev Kaila, John Milne
-
Publication number: 20110027216Abstract: Tissue adhesives formed by crosslinking albumin and/or gelatin with certain polyamines and/or polycarboxylates using a water-soluble carbodiimide are disclosed. The use of the tissue adhesives for medical and veterinary applications such as topical wound closure; and surgical procedures, such as intestinal anastomosis, vascular anastomosis, tissue repair, and ophthalmic procedures; drug delivery; anti-adhesive applications; and as a bulking agent to treat urinary incontinence are described.Type: ApplicationFiled: October 14, 2010Publication date: February 3, 2011Applicant: E.I. DU PONT DE NEMOURS AND COMPANYInventor: Henry Keith CHENAULT
-
Publication number: 20110027215Abstract: Tissue adhesives formed by crosslinking albumin and/or gelatin with certain polyamines and/or polycarboxylates using a water-soluble carbodiimide are disclosed. The use of the tissue adhesives for medical and veterinary applications such as topical wound closure; and surgical procedures, such as intestinal anastomosis, vascular anastomosis, tissue repair, and ophthalmic procedures; drug delivery; anti-adhesive applications; and as a bulking agent to treat urinary incontinence are described.Type: ApplicationFiled: October 14, 2010Publication date: February 3, 2011Applicant: E.I. DU PONT DE NEMOURS AND COMPANYInventor: Henry Keith CHENAULT
-
Publication number: 20110020264Abstract: A method and composition for treating healed wounds including hypertrophic scars so as to prevent scarring or reduce the size and improve the appearance of scars comprises applying to the healed wound or scar a composition comprising a fluid, film-forming carrier which may contain one or more active topical ingredients, the carrier hardening to a solid, tangible, membrane juxtaposed to the skin. Novel compositions using the film-forming carrier are also useful to treat a variety of adverse skin disorders, and internal physiological conditions.Type: ApplicationFiled: September 28, 2010Publication date: January 27, 2011Inventor: Joel R. Studin
-
Patent number: 7875294Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.Type: GrantFiled: September 28, 2006Date of Patent: January 25, 2011Assignee: Sessions Pharmaceuticals Inc.Inventors: Robert W. Sessions, Roger Sessions, legal representative, Alan R. Kahn
-
Patent number: RE42755Abstract: The present invention is directed to the use of honey in medical dressings. Preferred embodiments modify honey with a viscosity increasing agent, resulting in a range of possible compositions including ointments and salves, self-adhesive gels such as for use on mouth ulcers and pustules, and pliable or flexible sheets which can be used as a wound covering. Preferred viscosity increasing agents include both particulate and continuous gels, respective examples of each including agars and alginates. Selected honeys preferably, but not necessarily, exhibit antibacterial properties other than what is merely conferred by osmolarity and sugar concentration effects.Type: GrantFiled: December 11, 2000Date of Patent: September 27, 2011Assignee: Apimed Medical Honey LimitedInventor: Peter Molan